Abstract
HIV infection predisposes to cancer during childhood. In addition to the AIDS-defining non-Hodgkin lymphoma (NHL) and Kaposi sarcoma, a range of other lymphoid malignancies and solid tumors have been described. We report the first case of an HIV-positive child with thymic carcinoma in the setting of regressing thymic cysts. The tumor expressed CKIT but failed to respond to imatinab mesylate after a transient response to multiagent chemotherapy. This case extends the spectrum of pediatric malignancy in the setting of HIV and suggests that patients with presumed benign thymic cysts require ongoing surveillance.
2007 Wiley-Liss, Inc
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzamides
-
Child
-
Disease Progression
-
Follow-Up Studies
-
HIV Infections / complications*
-
HIV Infections / diagnosis
-
HIV Infections / therapy
-
Humans
-
Imatinib Mesylate
-
Liver Neoplasms / diagnosis*
-
Liver Neoplasms / secondary
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / secondary
-
Male
-
Mediastinal Cyst / complications
-
Mediastinal Cyst / diagnosis
-
Piperazines / therapeutic use
-
Pyrimidines / therapeutic use
-
Remission Induction
-
Thymoma / complications*
-
Thymoma / diagnosis
-
Thymoma / therapy
-
Thymus Neoplasms / complications*
-
Thymus Neoplasms / diagnosis
-
Thymus Neoplasms / therapy
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate